Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.

about

Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma.Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1.

P2860

Q48131164-024A2E5C-971B-4094-A0D9-ED05D29578C4 Q55336403-9E59E7B8-90C4-465B-97FB-957A2B32D13D

P2860

Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.

Item

http://www.wikidata.org/entity/Q41438064

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Association of dynamic suscept ...... y patients with glioblastomas.

@en

type

Item

label

Association of dynamic suscept ...... y patients with glioblastomas.

@en

prefLabel

Association of dynamic suscept ...... y patients with glioblastomas.

@en

P1476

Association of dynamic suscept ...... y patients with glioblastomas.

@en

P2093

Donald M O'Rourke

http://www.w3.org/2001/XMLSchema#string

Edward H Herskovits

http://www.w3.org/2001/XMLSchema#string

Elias R Melhem

http://www.w3.org/2001/XMLSchema#string

Kim O Learned

http://www.w3.org/2001/XMLSchema#string

Matthew R Voluck

http://www.w3.org/2001/XMLSchema#string

Pejman Jabehdar Maralani

http://www.w3.org/2001/XMLSchema#string

Sang Joon Kim

http://www.w3.org/2001/XMLSchema#string

Sumei Wang

http://www.w3.org/2001/XMLSchema#string

Suyash Mohan

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Epidemiologic and molecular prognostic review of glioblastoma

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.

Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy.

Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.

Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

P2888

s00330-015-3640-4

P304

2738-2744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-015-3640-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25680731

http://www.w3.org/2001/XMLSchema#string

Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.

about

P2860

P2860

Association of dynamic susceptibility contrast enhanced MR Perfusion parameters with prognosis in elderly patients with glioblastomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698